Ali A. Fadhil
Baghdad, BG, Iraq
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy.
Journal: Indian journal of clinical biochemistry : IJCB
Published: September 30, 2023
BTLA and HVEM: Emerging players in the tumor microenvironment and cancer progression.
Journal: Cytokine
Published: September 09, 2023
The emerging role of microRNA-126 as a potential therapeutic target in cancer: a comprehensive review.
Journal: Pathology, research and practice
Published: May 25, 2023
Role of the AMP-Activated Protein Kinase in the Pathogenesis of Polycystic Ovary Syndrome.
Journal: Indian journal of clinical biochemistry : IJCB
Published: April 14, 2023
NK cells direct the perspective approaches to cancer immunotherapy.
Journal: Medical oncology (Northwood, London, England)
Published: March 25, 2023
Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy.
Journal: Environmental research
Published: February 26, 2023
Peptide-Based Therapeutics in Cancer Therapy.
Journal: Molecular biotechnology
Published: February 24, 2023
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies.
Journal: Cancer metastasis reviews
Published: February 11, 2023
Phosphatidylinositol 3-kinase signaling pathway and inflammatory bowel disease: Current status and future prospects.
Journal: Fundamental & clinical pharmacology
Published: December 24, 2022
PDE5 inhibitors and gastric mucosa: implications for the management of peptic ulcer disease.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 06, 2022
Mitofusin-2 in cancer: Friend or foe?
Journal: Archives of biochemistry and biophysics
Published: July 02, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026